共 50 条
- [1] RLY-2608: The first allosteric mutant- and isoform-selective inhibitor of PI3Kα, is efficacious as a single agent and drives regressions in combination with standard of care therapies in PIK3CA mutant breast cancer models[J]. CANCER RESEARCH, 2022, 82 (04)Pazolli, ErmiraKipp, RandyBoezio, AlessandroGunaydin, HakanIskandar, AmandaZubrowski, MatthewWilliams, BretShortsleeves, KelleyLarivee, AlexandreMcLean, TomMichelsen, KlausZeng, HongtaoLaRochelle, JonathanManna, JoeDiPietro, LucianLescarbeau, AndreMader, MaryBennet, BinduWilbur, JeremyWang, QiPierce, LeviMartin, IainWatters, JamesFortin, PascalBergstrom, Donald
- [2] Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia[J]. CANCER DISCOVERY, 2024, 14 (02) : 240 - 257Varkaris, AndreasPazolli, ErmiraGunaydin, HakanWang, QiPierce, LeviBoezio, Alessandro A.Bulku, ArtemisaDipietro, LucianFridrich, CaryFrost, AdamGiordanetto, FabrizioHamilton, Erika P.Harris, KatherineHolliday, MichaelHunter, Tamieka L.Iskandar, AmandaJi, YongliLarivee, AlexandreLarochelle, Jonathan R.Lescarbeau, AndreLlambi, FabienLormil, BrendaMader, Mary M.Mar, Brenton G.Martin, IainMclean, Thomas H.Michelsen, KlausPechersky, YakovPuente-Poushnejad, ErikaRaynor, KevinRogala, DipaliSamadani, RaminSchram, Alison M.Shortsleeves, KelleySwaminathan, SwetaTajmir, ShaheinTan, GegeTang, YongValverde, RobertoWehrenberg, BryanWilbur, JeremyWilliams, Bret R.Zeng, HongtaoZhang, HanmoWalters, W. PatrickWolf, Beni B.Shaw, David E.Bergstrom, Donald A.Watters, JamesFraser, James S.
- [3] First-in-human global multi-center study of RLY-2608, a pan-mutant and isoform-selective PI3Kα inhibitor, as a single agent in patients with advanced solid tumors and in combination with fulvestrant in patients with advanced breast cancer[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Perez, Cesar AugustoHenry, Jason TimothyVarkaris, AndreasSubbiah, VivekSpira, Alexander I.Schmidt, OlegShen, JinshanGuo, WeiHunter, TamiekaJen, Kai YuPadval, MaheshKaranovic, DjuroWolf, Beni B.Hamilton, Erika P.
- [4] First-in-human study of RLY-2608, a pan-mutant and isoform selective PI3Kα inhibitor, as a single agent in patients (pts) with advanced solid tumors and in combination with fulvestrant in pts with advanced breast cancer[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Saura, CristinaSanz, LuciaKim, JaniceJhaveri, Komal L.Guerrero, AngelOrtega, Pablo TolosaSchott, Anne F.Curigliano, GiuseppePerez, Cesar AugustoNanda, RitaHamilton, Erika P.Henry, Jason TimothyWisinski, Kari BraunSammons, Sarah L.Segar, Jennifer MargaretAix, Santiago PonceSirven, Milana BergaminoSpira, Alexander I.Schram, Alison M.Varkaris, Andreas
- [5] Discovery of a Potent and Isoform-Selective Targeted Covalent Inhibitor of the Lipid Kinase PI3Kα[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (03) : 712 - 721Nacht, MarianaQiao, LixinSheets, Michael P.St. Martin, ThiaLabenski, MatthewMazdiyasni, HormozKarp, RussellZhu, ZhendongChaturvedi, PrasoonBhavsar, DeepaNiu, DeqiangWestlin, WilliamPetter, Russell C.Medikonda, Aravind PrasadSingh, Juswinder
- [6] First-in-human global multi-center study of RLY-2608, a pan mutant and isoform selective PI3Kα inhibitor, as a single agent in advanced solid tumor patients and in combination with fulvestrant in patients with advanced breast cancer[J]. CANCER RESEARCH, 2023, 83 (05)Varkaris, AndreasHamilton, ErikaHenry, JasonSpira, Alexander I.Schram, Alison M.McGuinness, Julia E.Tan, GegeLi, XiaoyanHunter, TamiekaSamadani, RaminTimm, AlisonKaranovic, DjuroSubbiah, VivekPerez, Cesar A.
- [7] PI3K Isoform-Selective Inhibitors in Cancer[J]. SINGLE-CELL SEQUENCING AND METHYLATION: METHODS AND CLINICAL APPLICATIONS, 2020, 1255 : 165 - 173Duncan, LeslieShay, ChloeTeng, Yong
- [8] Isoform-Selective PI3K Inhibitors for Various Diseases[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (12) : 1074 - 1092Bheemanaboina, Rammohan R. Y.
- [9] Discovery and characterization of PI3Kbeta isoform-selective inhibitors[J]. EJC SUPPLEMENTS, 2010, 8 (07): : 43 - 43Virone-Oddos, A.Halley, F.Delorme, C.Bonnevaux, H.Nicolas, J. P.Karlsson, A.Abecassis, P. Y.Vincent, L.Lengauer, C.
- [10] Discovery of a novel and potent mutant-selective inhibitor of PI3Kα[J]. CANCER RESEARCH, 2024, 84 (06)Gao, MingmingQi, ChaoLi, ZhentianFan, QipengWang, LiyangZhou, FeiYou, LinZheng, HewenLi, YuWu, LiangxingYao, WenqingLiu, Phillip C.